Vima Therapeutics

Developer of oral therapeutics designed for the treatment of movement disorders. The company offers clinical-stage biotechnology research focused on targeting the underlying causes of dystonia through...

Healthcare
Cambridge, MA, United States
Founded 2023
14 employees
Website
Valuation
$78M
Market implied
Share Price
N/A
Total Raised
$60M
Last Round
N/A

Get the full picture

Create a free account to unlock Vima Therapeutics's funding history, team members, investor details, and more.

15 free profiles/month · No credit card required